Childhood Kidney Diseases

Korean Society of Pediatric Nephrology (대한소아신장학회)
권호 표지
DOI QR코드

DOI QR Code

Risk Factors for the Progression of Chronic Kidney Disease in Children

  • Ahn, Yo Han (Department of Pediatrics, Seoul National University College of Medicine and Seoul National University Children's Hospital, Kidney Research Institute, Medical Research Center, Seoul National University College of Medicine) ;
  • Kang, Hee Gyung (Department of Pediatrics, Seoul National University College of Medicine and Seoul National University Children's Hospital, Kidney Research Institute, Medical Research Center, Seoul National University College of Medicine) ;
  • Ha, Il-Soo (Department of Pediatrics, Seoul National University College of Medicine and Seoul National University Children's Hospital, Kidney Research Institute, Medical Research Center, Seoul National University College of Medicine)
  • Received : 2021.03.02
  • Accepted : 2021.06.05
  • Published : 2021.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Chronic kidney disease (CKD) in children is associated with various complications, including poor growth and development, mineral bone disorder, cardiovascular disease, kidney failure, and mortality. Slowing down the progression of CKD is important since CKD is often not curable. Prospective cohort studies have been conducted to understand the progression and outcomes of CKD in children, and these studies have identified non-modifiable and modifiable risk factors. Recognition of known risk factors and early intervention are important to delay the progression of kidney function decline in children.

Keywords

References

  1. Becherucci F, Roperto RM, Materassi M, Romagnani P. Chronic kidney disease in children. Clin Kidney J 2016;9:583-91. https://doi.org/10.1093/ckj/sfw047
  2. Harambat J, van Stralen KJ, Kim JJ, Tizard EJ. Epidemiology of chronic kidney disease in children. Pediatr Nephrol 2012;27:363-73. https://doi.org/10.1007/s00467-011-1939-1
  3. Baek HS, Kang HG, Choi HJ, Cheong HI, Ha IS, Han KH, et al. Health-related quality of life of children with pre-dialysis chronic kidney disease. Pediatr Nephrol 2017;32:2097-105. https://doi.org/10.1007/s00467-017-3721-5
  4. Kang NR, Ahn YH, Park E, Choi HJ, Kim SH, Cho H, et al. Mental health and psychosocial adjustment in pediatric chronic kidney disease derived from the KNOW-Ped CKD study. Pediatr Nephrol 2019;34:1753-64. https://doi.org/10.1007/s00467-019-04292-w
  5. Saran R, Robinson B, Abbott KC, Agodoa LY, Albertus P, Ayanian J, et al. US Renal Data System 2016 annual data report: epidemiology of kidney disease in the United States. Am J Kidney Dis 2017;69(3 Suppl 1):A7-A8. https://doi.org/10.1053/S0272-6386(17)30043-4
  6. Atkinson MA, Ng DK, Warady BA, Furth SL, Flynn JT. The CKiD study: overview and summary of findings related to kidney disease progression. Pediatr Nephrol 2021;36:527-38. https://doi.org/10.1007/s00467-019-04458-6
  7. Querfeld U, Anarat A, Bayazit AK, Bakkaloglu AS, Bilginer Y, Caliskan S, et al. The Cardiovascular Comorbidity in Children with Chronic Kidney Disease (4C) study: objectives, design, and methodology. Clin J Am Soc Nephrol 2010;5:1642-8. https://doi.org/10.2215/CJN.08791209
  8. Kang HG, Choi HJ, Han KH, Kim SH, Cho HY, Cho MH, et al. KNOW-Ped CKD (KoreaN cohort study for outcomes in patients with pediatric CKD): Design and methods. BMC Nephrol 2016;17:35. https://doi.org/10.1186/s12882-016-0248-0
  9. Wuhl E, van Stralen KJ, Verrina E, Bjerre A, Wanner C, Heaf JG, et al. Timing and outcome of renal replacement therapy in patients with congenital malformations of the kidney and urinary tract. Clin J Am Soc Nephrol 2013;8:67-74. https://doi.org/10.2215/CJN.03310412
  10. Warady BA, Abraham AG, Schwartz GJ, Wong CS, Munoz A, Betoko A, et al. Predictors of rapid progression of glomerular and nonglomerular kidney disease in children and adolescents: the Chronic Kidney Disease in Children (CKiD) cohort. Am J Kidney Dis 2015;65:878-88. https://doi.org/10.1053/j.ajkd.2015.01.008
  11. Cerqueira DC, Soares CM, Silva VR, Magalhaes JO, Barcelos IP, Duarte MG, et al. A predictive model of progression of CKD to ESRD in a predialysis pediatric interdisciplinary program. Clin J Am Soc Nephrol 2014;9:728-35. https://doi.org/10.2215/CJN.06630613
  12. Chiou YY, Lin CY, Chen MJ, Chiou YH, Wang YF, Wang HH, et al. Etiology and pediatric chronic kidney disease progression: Taiwan Pediatric Renal Collaborative Study. J Formos Med Assoc 2016;115:752-63. https://doi.org/10.1016/j.jfma.2015.07.019
  13. Furth SL, Pierce C, Hui WF, White CA, Wong CS, Schaefer F, et al. Estimating time to ESRD in children with CKD. Am J Kidney Dis 2018;71:783-92. https://doi.org/10.1053/j.ajkd.2017.12.011
  14. Sutherland MR, Gubhaju L, Moore L, Kent AL, Dahlstrom JE, Horne RS, et al. Accelerated maturation and abnormal morphology in the preterm neonatal kidney. J Am Soc Nephrol 2011;22:1365-74. https://doi.org/10.1681/ASN.2010121266
  15. Greenbaum LA, Munoz A, Schneider MF, Kaskel FJ, Askenazi DJ, Jenkins R, et al. The association between abnormal birth history and growth in children with CKD. Clin J Am Soc Nephrol 2011;6:14-21. https://doi.org/10.2215/CJN.08481109
  16. Crump C, Sundquist J, Winkleby MA, Sundquist K. Preterm birth and risk of chronic kidney disease from childhood into mid-adulthood: national cohort study. BMJ 2019;365:l1346.
  17. Gjerde A, Lillas BS, Marti HP, Reisaeter AV, Vikse BE. Intrauterine growth restriction, preterm birth and risk of end-stage renal disease during the first 50 years of life. Nephrol Dial Transplant 2020;35:1157-63. https://doi.org/10.1093/ndt/gfaa001
  18. Gorriz JL, Martinez-Castelao A. Proteinuria: detection and role in native renal disease progression. Transplant Rev (Orlando) 2012;26:3-13. https://doi.org/10.1016/j.trre.2011.10.002
  19. Wong CS, Pierce CB, Cole SR, Warady BA, Mak RH, Benador NM, et al. Association of proteinuria with race, cause of chronic kidney disease, and glomerular filtration rate in the chronic kidney disease in children study. Clin J Am Soc Nephrol 2009;4:812-9. https://doi.org/10.2215/CJN.01780408
  20. Fuhrman DY, Schneider MF, Dell KM, Blydt-Hansen TD, Mak R, Saland JM, et al. Albuminuria, proteinuria, and renal disease progression in children with CKD. Clin J Am Soc Nephrol 2017;12:912-20. https://doi.org/10.2215/CJN.11971116
  21. Group ET, Wuhl E, Trivelli A, Picca S, Litwin M, Peco-Antic A, et al. Strict blood-pressure control and progression of renal failure in children. N Engl J Med 2009;361:1639-50. https://doi.org/10.1056/NEJMoa0902066
  22. Abraham AG, Betoko A, Fadrowski JJ, Pierce C, Furth SL, Warady BA, et al. Renin-angiotensin II-aldosterone system blockers and time to renal replacement therapy in children with CKD. Pediatr Nephrol 2017;32:643-9. https://doi.org/10.1007/s00467-016-3512-4
  23. Coppo R, Peruzzi L, Amore A, Piccoli A, Cochat P, Stone R, et al. IgACE: a placebo-controlled, randomized trial of angiotensin-converting enzyme inhibitors in children and young people with IgA nephropathy and moderate proteinuria. J Am Soc Nephrol 2007;18:1880-8. https://doi.org/10.1681/ASN.2006040347
  24. van den Belt SM, Heerspink HJL, Kirchner M, Gracchi V, Thurn-Valsassina D, Bayazit AK, et al. Discontinuation of RAAS inhibition in children with advanced CKD. Clin J Am Soc Nephrol 2020;15:625-32. https://doi.org/10.2215/CJN.09750819
  25. Ardissino G, Vigano S, Testa S, Dacco V, Paglialonga F, Leoni A, et al. No clear evidence of ACEi efficacy on the progression of chronic kidney disease in children with hypodysplastic nephropathy-report from the ItalKid Project database. Nephrol Dial Transplant 2007;22:2525-30. https://doi.org/10.1093/ndt/gfm237
  26. Griffin KA. Hypertensive kidney injury and the progression of chronic kidney disease. Hypertension 2017;70:687-94. https://doi.org/10.1161/HYPERTENSIONAHA.117.08314
  27. Flynn JT, Mitsnefes M, Pierce C, Cole SR, Parekh RS, Furth SL, et al. Blood pressure in children with chronic kidney disease: a report from the Chronic Kidney Disease in Children study. Hypertension 2008;52:631-7. https://doi.org/10.1161/HYPERTENSIONAHA.108.110635
  28. Barletta GM, Pierce C, Mitsnefes M, Samuels J, Warady BA, Furth S, et al. Is blood pressure improving in children with chronic kidney disease? A period analysis. Hypertension 2018;71:444-50. https://doi.org/10.1161/HYPERTENSIONAHA.117.09649
  29. The Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO clinical practice guideline for the management of blood pressure in chronic kidney disease. Kidney Int Suppl 2012;2:337-414. https://doi.org/10.1038/kisup.2012.46
  30. Khurana M, Silverstein DM. Etiology and management of dyslipidemia in children with chronic kidney disease and end-stage renal disease. Pediatr Nephrol 2015;30:2073-84. https://doi.org/10.1007/s00467-015-3075-9
  31. Baek HS, Kim SH, Kang HG, Choi HJ, Cheong HI, Ha IS, et al. Dyslipidemia in pediatric CKD patients: results from KNOW-PedCKD (KoreaN cohort study for Outcomes in patients With Pediatric CKD). Pediatr Nephrol 2020;35:1455-61. https://doi.org/10.1007/s00467-020-04545-z
  32. Saland JM, Pierce CB, Mitsnefes MM, Flynn JT, Goebel J, Kupferman JC, et al. Dyslipidemia in children with chronic kidney disease. Kidney Int 2010;78:1154-63. https://doi.org/10.1038/ki.2010.311
  33. Saland JM, Kupferman JC, Pierce CB, Flynn JT, Mitsnefes MM, Warady BA, et al. Change in dyslipidemia with declining glomerular filtration rate and increasing proteinuria in children with CKD. Clin J Am Soc Nephrol 2019;14:1711-8. https://doi.org/10.2215/CJN.03110319
  34. Khurana M, Silverstein DM. Etiology and management of dyslipidemia in children with chronic kidney disease and end-stage renal disease. Pediatr Nephrol 2015;30:203-84.
  35. Kidney Disease: Improving Global Outcomes (KDIGO) Lipid Work Group. KDIGO clinical practice guideline for lipid management in chronic kidney disease. Kidney Int Suppl 2013;3:259-305. https://doi.org/10.1038/kisup.2013.27
  36. Johnson RJ, Nakagawa T, Jalal D, Sanchez-Lozada LG, Kang DH, Ritz E. Uric acid and chronic kidney disease: which is chasing which? Nephrol Dial Transplant 2013;28:2221-8. https://doi.org/10.1093/ndt/gft029
  37. Rodenbach KE, Schneider MF, Furth SL, Moxey-Mims MM, Mitsnefes MM, Weaver DJ, et al. Hyperuricemia and progression of CKD in children and adolescents: the Chronic Kidney Disease in Children (CKiD) cohort study. Am J Kidney Dis 2015;66:984-92. https://doi.org/10.1053/j.ajkd.2015.06.015
  38. Sampson AL, Singer RF, Walters GD. Uric acid lowering therapies for preventing or delaying the progression of chronic kidney disease. Cochrane Database Syst Rev 2017;10:CD009460.
  39. Oh TR, Choi HS, Kim CS, Bae EH, Ma SK, Sung SA, et al. Hyperuricemia has increased the risk of progression of chronic kidney disease: propensity score matching analysis from the KNOW-CKD study. Sci Rep 2019;9:6681. https://doi.org/10.1038/s41598-019-43241-3
  40. Atkinson MA, Furth SL. Anemia in children with chronic kidney disease. Nat Rev Nephrol 2011;7:635-41. https://doi.org/10.1038/nrneph.2011.115
  41. Kim JY, Lee Y, Kang HG, Ha IS, Cheong HI, Choi HJ, et al. Left-ventricular diastolic dysfunction in Korean children with chronic kidney disease: data from the KNOW-Ped CKD study. BMC Nephrol 2020;21:533. https://doi.org/10.1186/s12882-020-02152-6
  42. Fadrowski JJ, Pierce CB, Cole SR, Moxey-Mims M, Warady BA, Furth SL. Hemoglobin decline in children with chronic kidney disease: baseline results from the chronic kidney disease in children prospective cohort study. Clin J Am Soc Nephrol 2008;3:457-62. https://doi.org/10.2215/CJN.03020707
  43. Lee KH, Park E, Choi HJ, Kang HG, Ha IS, Cheong HI, et al. Anemia and iron deficiency in children with chronic kidney disease (CKD): Data from the Know-Ped CKD study. J Clin Med 2019;8:152. https://doi.org/10.3390/jcm8020152
  44. Furth SL, Cole SR, Fadrowski JJ, Gerson A, Pierce CB, Chandra M, et al. The association of anemia and hypoalbuminemia with accelerated decline in GFR among adolescents with chronic kidney disease. Pediatr Nephrol 2007;22:265-71. https://doi.org/10.1007/s00467-006-0313-1
  45. Gouva C, Nikolopoulos P, Ioannidis JP, Siamopoulos KC. Treating anemia early in renal failure patients slows the decline of renal function: a randomized controlled trial. Kidney Int 2004;66:753-60. https://doi.org/10.1111/j.1523-1755.2004.00797.x
  46. Garimella PS, Katz R, Patel KV, Kritchevsky SB, Parikh CR, Ix JH, et al. Association of serum erythropoietin with cardiovascular events, kidney function decline, and mortality: the Health Aging and Body Composition study. Circ Heart Fail 2016;9:e002124.
  47. The Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO clinical practice guideline for anemia in chronic kidney disease. Kidney Int Suppl 2012;2:279-335. https://doi.org/10.1038/kisup.2012.37